Overview
Innovative Industrial Properties Q2 revenue misses analyst expectations, down 21% yr/yr
Net income for Q2 declines significantly compared to last year
Co repurchased $20 mln of common stock, maintaining liquidity over $190 mln
Result Drivers
TENANT DEFAULTS - Tenant defaults, including PharmaCann and others, led to a $15.8 mln revenue decline
PROPERTY SALES - Revenue decreased due to properties vacated or sold, impacting income by $1.3 mln
NEW LEASES - Revenue partially offset by $1.5 mln increase from new leases on existing properties
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Revenue | Miss | $62.90 mln | $63.90 mln (5 Analysts) |
Q2 Net Income | $25.10 mln |
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy", 3 "hold" and 2 "sell" or "strong sell"
The average consensus recommendation for the commercial reits peer group is "buy."
Wall Street's median 12-month price target for Innovative Industrial Properties Inc is $53.00, about 1.3% above its August 5 closing price of $52.29
The stock recently traded at 11 times the next 12-month earnings vs. a P/E of 13 three months ago
Press Release: ID:nBw4xjlk9a
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.